It’s worth trialing, but let’s be clear about the priors. The scant data we have are consistent with the expectation of a short-lived and non-anamnestic immune response after a first priming dose. It would be great if the SARS-CoV2 spike protein is the exception to this rule.
-
-
And I think the converse is true as well. A comedy, a tragedy of errors.
-
But what about a middle ground?https://twitter.com/sdbaral/status/1341912833462829056 …
- Show replies
New conversation -
-
-
Yes,
@zeynep but there are people in the scientific community who are interested in science communication--it's an entire sub-field--and who study public perceptions of science. So just don't want to be categorical. -
And there is the further question that this is not just about understanding. It’s about practical reason: How should I act? Should i prioritize getting a second shot even if it is complicated for me to get it? I read I don’t need it.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.